GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
The recognition of mRNA molecules as a transformative class of therapeutic drugs has soared, particularly with the development of COVID 19 mRNA vaccines. The cancer treatment landscape is similarly ...
RNA interference (RNAi) is making great strides as an indispensable strategy for target-specific knockdown of gene expression. Emerging second-generation technologies represent advances in RNAi design ...
The discovery of siRNA and its role in RNAi was a groundbreaking finding in the field of molecular biology. In 1998, Andrew Fire and Craig Mello published a seminal paper describing the phenomenon of ...
In a press release from the University of California — Riverside, one of the researchers behind the new RNA vaccine, Rong Hai, explained why he and his colleagues are so excited about their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback